Fresenius Medical Care

Fresenius Medical Care, headquartered in the US, reported total emissions of approximately 3.86 billion kg CO2e in 2024. This figure includes Scope 1, Scope 2, and Scope 3 emissions.

Emissions Breakdown:

• Scope 1 Emissions: In 2024, direct emissions (Scope 1) were about 360.8 million kg CO2e.
• Scope 2 Emissions: Market-based indirect emissions from purchased electricity (Scope 2) were approximately 326.6 million kg CO2e in 2024, while location-based Scope 2 emissions were around 450.6 million kg CO2e.
• Scope 3 Emissions: Value chain emissions (Scope 3) totalled approximately 31 million kg CO2e in 2024. Key contributors to Scope 3 emissions in 2024 included purchased goods and services (around 1.46 billion kg CO2e), use of sold products (about 847.3 million kg CO2e), employee commute (approximately 192.4 million kg CO2e), and upstream transportation and distribution (around 194.3 million kg CO2e).

Looking at projections for 2025, Fresenius Medical Care anticipates a total of approximately 31.43 million kg CO2e across all scopes.

Climate Commitments and Targets: Fresenius Medical Care has set ambitious climate targets:

• Near-Term Targets: The company aims to reduce absolute Scope 1 and Scope 2 GHG emissions by 50% by 2030, compared to a 2020 base year. Additionally, they are committed to reducing absolute Scope 3 GHG emissions from fuel- and energy-related activities, business travel, and use of sold products by 25% by 2030, against a 2024 base year.
• Long-Term Targets: Fresenius Medical Care commits to achieving net-zero greenhouse gas emissions across its entire value chain by 2050. This includes a 90% reduction in absolute Scope 1 and 2 GHG emissions by 2050 from a 2020 base year, and a 90% reduction in absolute Scope 3 GHG emissions by 2050 from a 2024 base year. These targets have been validated by the Science Based Targets initiative (SBTi) and are consistent with a 1.5°C global warming scenario. The company also states an aim to achieve climate neutrality in operations by 2040.